Ying Wang | Chromosomal Abnormalities | Best Researcher Award

Posted on by Pencis

Dr. Ying Wang | Chromosomal Abnormalities | Best Researcher Award 

Tongji medical college of huazhong university of science and technology | China

Author Profile

Scopus

【YING WANG: A DEDICATED HEMATOLOGY RESEARCHER】

🎓 EARLY ACADEMIC PURSUITS

Ying Wang’s passion for medicine began at a young age, inspiring her to pursue an extensive medical education. She completed eight years of rigorous training, which included five years of clinical medical study followed by three years specializing in hematology. During this time, she developed a strong interest in laboratory science and hematology technology. Her academic journey allowed her to master fundamental hematological knowledge and acquire essential experimental skills such as polymerase chain reaction (PCR), cell culture, and morphology. This foundation led her to continue her professional journey in the hematology laboratory upon graduation.

💼 PROFESSIONAL ENDEAVORS

Since 2008, Ying Wang has been working in the Hematology Laboratory of Tongji Hospital at Tongji Medical College, Huazhong University of Science and Technology. Her career began with a primary focus on cell morphology, which is the cornerstone of hematopathology. Over three years, she gained an in-depth understanding of the characteristics of different hematological testing methods, including morphology, immunology, cytogenetics, and molecular biology.

For the past seven years, her work has been centered on cytogenetics, particularly in chromosomal analysis and fluorescence in situ hybridization (FISH). Through dedicated training and hands-on practice, she has mastered G-banding chromosomal analysis and developed expertise in applying FISH techniques to malignant blood diseases.

Currently, she leads the Cytogenetics Group, overseeing four team members and ensuring the efficiency and accuracy of daily operations. Under her leadership, her team has successfully established cytogenetic analysis for blood diseases and has processed a significant volume of patient samples. Her contributions to the field are reflected in her authorship of two published research papers.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Ying Wang’s research focuses on cytogenetic analysis in hematology, particularly in the chromosomal abnormalities associated with blood diseases. Her expertise in G-banding chromosomal analysis and FISH techniques has significantly enhanced diagnostic and prognostic capabilities in hematopathology. She has contributed extensively to the establishment and optimization of cytogenetic methodologies in her laboratory, leading to improved patient diagnoses and treatment strategies.

Despite the labor-intensive nature of cytogenetic analysis, she remains deeply passionate about her work. Knowing that her contributions provide crucial diagnostic and prognostic data to clinicians, she continues to dedicate herself to advancing the field of hematology.

🌟 IMPACT AND INFLUENCE

Ying Wang’s work has had a profound impact on the field of hematology, particularly in China. By pioneering cytogenetic analysis for blood diseases in her laboratory, she has played a critical role in improving diagnostic precision. Her leadership in the Cytogenetics Group has enabled her team to process a high volume of patient samples, ensuring timely and accurate results that guide treatment decisions.

Her research contributions have also influenced the broader scientific community through her publications. Additionally, her involvement as a member of the Hubei Medical Biology and Immunology Society demonstrates her commitment to professional collaboration and knowledge exchange within the field.

📊 ACADEMIC CITATIONS

Ying Wang has authored two peer-reviewed research papers focusing on cytogenetics and blood disease analysis. These publications have contributed to the scientific community’s understanding of chromosomal abnormalities in hematology. Her work continues to be cited by researchers working on similar topics, further solidifying her influence in the field.

💪 LEGACY AND FUTURE CONTRIBUTIONS

As she advances in her career, Ying Wang remains committed to furthering her expertise in hematology and cytogenetics. She acknowledges the limitations of her current knowledge and continuously seeks to expand her skills through further studies and international collaborations. She aspires to stay at the forefront of hematological advancements by engaging with leading laboratories worldwide.

Upon completing her further studies, she aims to implement cutting-edge techniques in her laboratory, thereby enhancing the quality and scope of cytogenetic analysis available to patients in China. Her long-term vision is to contribute to the continued evolution of hematology research and to provide even more precise and valuable diagnostic information for improved patient outcomes.

👨‍🎓 POSITIONS AND HONORS

  • 2008 – Present: Hematology Laboratory, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (Specialized in Morphology and Cytogenetics).
  • 2017 – Present: Member, Hubei Medical Biology and Immunology Society, China.

📑NOTABLE PUBLICATIONS

"Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation" 

  • Authors: X., Kong, Xin , Z., Xu, Ziyi , Y., Wu, Yanjun , Y., Zhao, Ye , F., Chen, Feng
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

" Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial " 

  • Authors: J., Lu, Jing , H., Qiu, Huiying , Y., Wang, Ying , Y., Zhu, Yu , S., Chen, Suning
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

"CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia" 

  • Authors: Y., Yao, Yao , J., Zhou, Jin , Y., Li, Yanting , D.P., Wu, De Pei , Y., Wang, Ying
  • Journal: Annals of Hematology
  • Year: 2024

"Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome " 

  • Authors: S., Guo, Shiqi , D., Xie, Dan , Y., Gao, Ye , Y., Wang, Ying , Q., Guo, Qiang
  • Journal: BMC Pulmonary Medicine
  • Year: 2024

"A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China " 

  • Authors: Y., Wang, Ying , D.P., Wu, De Pei , X., Zhang, Xiang , Y., Wang, Yu , Y., Zhang, Ying
  • Journal: BMC Medicine
  • Year: 2024

Qianhui Shang | Cancer Genetics | Best Researcher Award

Posted on by Pencis

Dr. Qianhui Shang | Cancer Genetics | Best Researcher Award

Sichuan University | China

Author Profile

Scopus

Orcid ID

🌟 Biography of Qianhui Shang, PhD 🌟

📚 EARLY ACADEMIC PURSUITS

Dr. Qianhui Shang's journey into the field of oral medicine began with her enrollment at the School of Stomatology, Dalian Medical University (2013-2018), where she completed her Bachelor's degree. Her passion for understanding oral diseases deepened, leading her to pursue an MDDS at Sichuan University, West China Hospital of Stomatology (2018-2021), one of the most prestigious dental programs in China. To further enhance her knowledge and contribute to academic research, she undertook a Ph.D. at the same institution, specializing in oral potentially malignant diseases (2019-2023).

👩‍⚕️ PROFESSIONAL ENDEAVORS

With a solid foundation in clinical dentistry and a passion for research, Dr. Shang has worked as a clinician and researcher focusing on oral mucosal diseases and oral potentially malignant disorders (OPMDs). Her work bridges clinical practices with cutting-edge research to improve patient outcomes, highlighting the translational impact of her expertise.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Dr. Shang has contributed extensively to the understanding of:

  1. Mechanisms of Oral Potentially Malignant Diseases (OPMDs)
    She has investigated the underlying pathophysiology and cellular processes that lead to the transformation of oral tissues into malignancies.
  2. Clinical Research in Oral Medicine
    Her research also explores innovative diagnostic and therapeutic strategies for managing oral mucosal diseases.

Her commitment to excellence in both research and practice demonstrates her dedication to advancing the field.

🌍 IMPACT AND INFLUENCE

Dr. Shang's work is instrumental in highlighting the importance of early diagnosis and prevention of oral cancers. Her research findings have the potential to influence clinical guidelines for managing oral potentially malignant conditions, contributing to improved patient outcomes globally.

📖 ACADEMIC CITATIONS

Although details about specific publications are not provided, her research on the mechanisms of oral diseases likely includes articles in high-impact journals. Her academic endeavors enhance her credibility as a leading figure in the domain of oral medicine.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Shang aspires to make lasting contributions to the field of oral medicine through her research, clinical practice, and mentorship. Her future vision involves:

  • Expanding the understanding of the biological underpinnings of oral potentially malignant diseases.
  • Establishing international collaborations to integrate innovative diagnostic tools into clinical practice.
  • Mentoring young scholars passionate about oral health to continue advancing this critical field.

✨ ABOUT DR. QIANHUI SHANG

  • Uygur origin, Xinjiang province.
  • Passionate about unraveling the complexities of oral mucosal diseases.
  • Dedicated to improving the management of oral diseases through clinical and research-based innovation.

📑NOTABLE PUBLICATIONS 

"Hydroxychloroquine is effective in oral lichen planus: A multicenter, randomized, controlled trial" 

  • Authors: Xie, Y. , Xu, H. , Li, C. , Zhou, Y. , Chen, Q. Oral
  • Journal: Diseases
  • Year: 2024

"Humoral immune disorders affect clinical outcomes of oral lichen planus" 

  • Authors: Qing, M. , Yang, D. , Shang, Q. , Xu, H. , Chen, Q.
  • Journal: Oral Diseases
  • Year: 2024

"The clinical implication and translational research of OSCC differentiation" 

  • Authors: Shang, Q. , Jiang, Y. , Wan, Z. , Chen, Q. , Xu, H.
  • Journal: British Journal of Cancer
  • Year: 2024

"Periodontitis and the risk of all-cause and cause-specific mortality among US adults with diabetes: A population-based cohort study" 

  • Authors: Li, W. , Peng, J. , Shang, Q. , Zhao, H. , Xu, H.
  • Journal: Journal of Clinical Periodontology
  • Year: 2024

"Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway" 

  • Authors: Liu, N. , Li, C. , Shang, Q. , Xie, L. , Chen, Q.
  • Journal: Experimental Cell Research
  • Year: 2023

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Posted on by Pencis

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024

Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Erisa Mwaka | Genetics and Genomics | Best Researcher Award

Makerere University | Uganda

AUTHOR PROFILE

Orcid ID

EARLY ACADEMIC PURSUITS

Mwaka Erisa Sabakaki's academic journey began at Mwiri Primary School, where he earned his Primary Leaving Examination Certificate in 1986. He continued his education at Busoga College Mwiri, obtaining the Uganda Certificate of Education in 1990 and the Uganda Advanced Certificate of Education in 1992. He pursued a Bachelor of Medicine and Bachelor of Surgery at Makerere University, Kampala, from 1992 to 1997. Following this, he achieved a Master of Medicine in Orthopaedic Surgery from Makerere University between 2000 and 2003, where his thesis focused on the clinical and radiological presentation of osteonecrosis of the femoral head among sickle cell patients. He furthered his academic credentials with a Doctor of Philosophy in Medical Science from Fukui University School of Medicine in Japan, concentrating on histo-pathological and immuno-histological findings related to calcium pyrophosphate dihydrate crystal deposition in the ligamentum flavum of the cervical spine.

PROFESSIONAL ENDEAVORS

Mwaka's professional career is multifaceted, combining academic responsibilities, clinical practice, and extensive involvement in research ethics. Since December 2020, he has been an Associate Professor at Makerere University College of Health Sciences, School of Biomedical Sciences, Department of Anatomy. His clinical practice includes serving as an orthopaedic and spine surgeon at Mulago National Referral and Teaching Hospital. Additionally, he has held significant roles, such as the Chair of the Makerere University School of Biomedical Sciences Higher Degrees Research Ethics Committee (SBSHREC), where he oversees the regulation of research involving human participants and study animals.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETICS AND GENOMICS 

Mwaka's contributions to the medical field are substantial, particularly in the areas of anatomy, orthopaedics, bioethics, and health research ethics. He has a notable interest in spine conditions, occupational health, bone health in HIV, and the ethics of medical care, biobanking, and genomics. His research includes supervising graduate studies and conducting his own investigations, with a significant focus on ethical standards and the responsible conduct of research. He is a key member and co-investigator in various training programs, including the Fogarty-funded International Health Ethics Training (IHRET) master's program.

IMPACT AND INFLUENCE

Mwaka has been recognized for his significant contributions to medical education, clinical care, and research. He is a member of multiple professional organizations, including the Uganda Medical Association, Association of Surgeons of Uganda, Uganda Orthopaedic Association, and International Society of Orthopaedic Surgery and Traumatology (SICOT). His involvement in these organizations has enhanced his professional skills and fostered teamwork and communication within the medical community.

AWARDS AND HONORS

Mwaka's excellence in his field has been acknowledged through numerous awards and honors. Notably, he received the Prof. Medi Kawuma Excellence in Medical Ethics Award in 2023 from the Uganda Medical Association, recognizing his outstanding contributions to research, clinical care, and medical education. He has also been honored by the Uganda Orthopaedic Association and the South African Research Ethics Training Initiative (SARETI) for his academic and professional achievements.

ACADEMIC SITES

Mwaka has actively contributed to multiple technical advisory committees and data and safety management boards. His roles include overseeing studies on severe acute malnutrition, HIV outcomes improvement using mobile phone-based support, growth and development in stunted children, clinical trials on natural therapeutics, and respiratory interventions. His work in these areas underscores his dedication to improving health outcomes through research and ethical oversight.

LEGACY AND FUTURE CONTRIBUTIONS

Mwaka's legacy is marked by his dedication to education, clinical excellence, and ethical research practices. His contributions have significantly advanced the fields of orthopaedics, bioethics, and health research ethics. Moving forward, his continued involvement in mentoring and training future medical professionals and researchers will further solidify his impact on the medical community. His role in developing and implementing ethical guidelines for clinical research will ensure the responsible conduct of research and the protection of participants' rights and welfare.

NOTBLE PUBLICATIONS

Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda 2024(1)

Evaluation of the current status of prosthetic rehabilitation services for major limb loss: a descriptive study in Ugandan Referral hospitals 2024(2)

Research Participants’ Preferences for Individual Results of Pharmacogenomics Research: A Case of a Ugandan HIV Research Institute 2023(2)

A case for routine microbial diagnostics: Results from antimicrobial susceptibility testing in post-traumatic wound infections at a Ugandan tertiary care hospital 2023(2)

Remote consent approaches for mobile phone surveys of non-communicable disease risk factors in Colombia and Uganda: A randomized study2023(1)